AngioDynamics Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Net Income	-36.74	-33.99	-184.35	-52.44	-26.55
Depreciation & Amortization	22.96	25.8	27.71	30.87	29.35
Stock-Based Compensation	13.96	9.77	10.53	11.16	10.69
Other Adjustments	5.57	2.41	103.53	17.52	0.36
Change in Receivables	-5.75	0.02	7.89	-1.3	-17.15
Changes in Inventories	10.05	-1.35	-9.41	-8.2	-2.8
Changes in Accounts Payable	-5.83	-15.88	27.53	2.14	3.91
Changes in Other Operating Activities	-1.12	3.09	-11.59	0.33	-5.01
Operating Cash Flow	3.09	-10.13	-28.16	0.08	-7.19
Capital Expenditures	-5.95	-10.18	-7.53	-9.21	-15.71
Sale of Property, Plant & Equipment	-	-	134.5	-	-
Purchases of Intangible Assets	-	-	-3.25	-0.54	-
Payments for Business Acquisitions	-	-	-	-	-3.6
Investing Cash Flow	-5.95	-10.18	123.72	-9.75	-19.31
Long-Term Debt Issued	-	6.31	-	70	5
Long-Term Debt Repaid	-0.38	-0.15	-50	-45	-
Net Long-Term Debt Issued (Repaid)	-0.38	6.16	-50	25	5
Issuance of Common Stock	0.94	0.93	0.75	1.17	2.68
Repurchase of Common Stock	-	-1.67	-	-	-
Net Common Stock Issued (Repurchased)	0.94	-0.74	0.75	1.17	2.68
Other Financing Activities	-	-5.68	-15	-0.75	-
Financing Cash Flow	0.56	-0.26	-64.25	25.42	7.68
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.27	0.4	0.13	0.04	-0.52
Net Cash Flow	-2.03	-20.16	31.44	15.8	-19.34
Free Cash Flow	-2.86	-20.31	-35.69	-9.13	-22.9
FCF Margin	-0.89%	-6.94%	-11.74%	-2.69%	-7.24%
Free Cash Flow Per Share	-0.07	-0.50	-0.89	-0.23	-0.59
Levered Free Cash Flow	-17.02	-26.34	-207.64	-11.5	-11.8
Unlevered Free Cash Flow	-20.32	-38.42	-158.41	-33.37	-15.49

SEC Filings: 10-K · 10-Q